Willkommen, schön sind Sie da!
Logo Ex Libris

Analysis of the Regulatory Requirements for Biosimilars in the EU

  • Kartonierter Einband
  • 68 Seiten
(0) Erste Bewertung abgeben
Bewertungen
(0)
(0)
(0)
(0)
(0)
Alle Bewertungen ansehen
A biosimilar is a biological medicinal product which is a copy of an original (innovator) product. The innovator product is often ... Weiterlesen
CHF 29.30
Auslieferung erfolgt in der Regel innert 2 bis 4 Werktagen.
Bestellung & Lieferung in eine Filiale möglich

Beschreibung

A biosimilar is a biological medicinal product which is a copy of an original (innovator) product. The innovator product is often manufactured by a different company and after the patent of the innovator product expires a biosimilar can be registered in the European Union to a lower price than the innovator product. The first biosimilar in the European Union was registered in 2006 and was a Somatropin compound. Now are about 20 biosimilars registered in the European Union. Forecasts expect that there will be a huge amount of biosimilars pushing on the market in the near future and that will have a big influence on the industry.

Produktinformationen

Titel: Analysis of the Regulatory Requirements for Biosimilars in the EU
Untertitel: A General Overview
Autor:
EAN: 9783639888812
Format: Kartonierter Einband
Genre: Medizin
Anzahl Seiten: 68
Gewicht: 107g
Größe: H3mm x B220mm x T150mm